Can a simple blood test predict kidney trouble in heart failure treatment?
NCT ID NCT00561483
Summary
This study aimed to understand if tracking a blood marker called cystatin C could give doctors early warning that a patient's kidneys might be harmed by the fluid-removing (diuretic) drugs used to treat sudden heart failure. Researchers followed 64 hospitalized patients, taking daily blood samples to see how cystatin C levels changed compared to standard kidney tests. The goal was to gather information to help design future studies that could make heart failure treatment safer for the kidneys.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
Conditions
Explore the condition pages connected to this study.